Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101.

Of these 70 patients (36 completing myeloablative consolidation and 34 completing nonmyeloablative consolidation), there was a nonsignificant trend for longer PFS in the myeloablative arm than the nonmyeloablative arm (HR, 0.58; 95% CI, 0.25-1.36; P = .21), with estimated 2-year PFS rates after the start of consolidation of 86% (95% CI, 69-94) vs 71% (95% CI, 52-83), respectively ( Figure 3 B).

also in 5,406 other papers